Citi tells investors it’s time to sell Moderna after 600%-plus stock gains

Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.

Previous Article

‘I’m afraid of human stupidity’: Why this top economist prefers U.S. tech and gold over bonds

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨